Article · Wikipedia archive · Last revised Jul 15, 2026

Gefarnate

Gefarnate is a drug used for the treatment of gastric ulcers.

Last revised
Jul 15, 2026
Read time
≈ 1 min
Length
169 w
Citations
3
Source
Wikipedia ↗
Gefarnate
Skeletal formula
Space-filling model
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • (2E)-3,7-dimethylocta-2,6-dien-1-yl (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.111
Chemical and physical data
FormulaC27H44O2
Molar mass400.647 g·mol−1
3D model (JSmol)
  • CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(C)/CCC=C(C)C
  • InChI=1S/C27H44O2/c1-22(2)12-8-14-24(5)16-10-17-25(6)18-11-19-27(28)29-21-20-26(7)15-9-13-23(3)4/h12-13,16,18,20H,8-11,14-15,17,19,21H2,1-7H3/b24-16+,25-18+,26-20+ X markN
  • Key:ZPACYDRSPFRDHO-ROBAGEODSA-N X markN
 X markNcheckY (what is this?)  (verify)

Gefarnate is a drug used for the treatment of gastric ulcers.1

It also has been proposed for use in the treatment of dry eye syndrome.23

References

References

  1. Ohta Y, Kobayashi T, Imai Y, Inui K, Yoshino J, Nakazawa S (August 2005). "Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone". Biol. Pharm. Bull. 28 (8): 1424–30. doi:10.1248/bpb.28.1424. PMID 16079487.
  2. Peral A, Domínguez-Godínez CO, Carracedo G, Pintor J (April 2008). "Therapeutic targets in dry eye syndrome". Drug News Perspect. 21 (3): 166–76. doi:10.1358/dnp.2008.21.3.1203413. PMID 18560615.
  3. Gipson IK, Hori Y, Argüeso P (April 2004). "Character of ocular surface mucins and their alteration in dry eye disease". Ocul Surf. 2 (2): 131–48. doi:10.1016/s1542-0124(12)70149-0. PMID 17216084.